Blogs about Biotechnology, Pharmaceutical and Healthcare

07:16 EDT 20th October 2014 | BioPortfolio

Read the latest opinions - blogs from pharmaceutical and life science industry experts.

Showing News Articles 1–25 of 61,000+

Monday 20th October 2014

Snapshot: Dana Scoville

Meet Dana Scoville of Counseling and Psychological Services, Scripps Florida.

Researchers Receive $6.6 Million to Investigate Deadly Lassa Virus

The effort, led by the Oldstone lab, aims to uncover how the virus causes disease, as well as why some patients die while others survive.

Update: Amarin Announces Its Q3 2014 Cash Balance

By Elephant Analytics:Amarin (NASDAQ:AMRN) mentioned in an SEC filing on October 16 that it expected cash and cash equivalents to be approximately $135.4 million at the end of Q3 2014. This puts it on track to meet its target of keeping cash outflows to $80 million in 2014, which would require a year end cash balance of $111.5 million. This is better than my year end projection for $100.6 million ...

Do travel bans work?

According to Vox, the answer is ‘no’.  The reason isn’t because travel bans don’t work in theory; it is because in practice travel bans  are never perfectly enforceable and thus may cause more harm than they help. But there&...

Sunday 19th October 2014

New Thinking Needed To Invigorate Japan Pharma Innovation

If Japan is to invigorate pharma and biotech innovation there will need to be changes to ways of thinking by both investors and research-based ventures, along with closer co-ordination between academia, industry and the government, suggested particip...

Herbalife: On The Crime Prevention Beat

By Rogier van Vlissingen: You can fool all the people some of the time, and some of the people all the time, but you cannot fool all the people all the time. Abraham Lincoln While Wall Street waits with bated breath for the latest reporting by Herbalife (NYSE:HLF), on main street, in communities around the country it is down to simple crime prevention. Meanwhile Al Jazeera America scoo...

Ebola Vaccine Push Ramps Up

The world had little interest in Ebola in 1997, when cell biologist Nancy J. Sullivan took up her work. Today, Dr. Sullivan would likely be at the center of any potential answer to the world’s severest Ebola outbreak.

Top stories in health and medicine, October 20, 2014

From MedPage Today: Ebola: Politicos Mull Travel Restrictions; Docs Say No. As Ebola continues to dominate the headlines, one hotly debated question is whether the U.S. should ban travelers from the West Africa nations where the disease is raging, as a preventive measure. Ebola: Do the Dogs Have It? Bentley, the dog of Ebola patient Nina […]

Greenpeace on Golden Rice...QUOTE :... it doesn't actually exist yet.

Source: BBC Radio 4: Today ProgrammeDate: 15/10/2014Event: Greenpeace's Doug Parr on stem cells, Golden Rice and Pascal HustingCredit: BBC Radio 4: Today ProgrammePeople:Professor Pete Coffey: Professor of Cellular Therapies, UCLDr. Patrick Moore: Canadian ecologist and campaignerDr. Doug Parr: Chief Scientist and Policy Director, Greenpeace UK...Justin Webb: Presenter, BBC Radio 4 Today Programme...

NAD Advises Disclosures For Native Advertising Ahead Of FTC Guidance

Ads designed to blend in with the platform where it appears can mislead consumers that the material is news content. Firms employing native advertising or sponsored content marketing should disclose their affiliation with external websites or links u...

Open Access Week: the next generation

Open Access Week, a global event now entering its eighth year and running from the 20th – 26th October, is an opportunity for the academic and research community to continue to learn about the potential benefits of Open Access, to share what they’ve learned with colleagues, and to help inspire wider participation in helping to […]

Claret Targets TAVR Stroke Risk With Sentinel Embolic Filter Device

The company launched the SENTINEL trial in the U.S., the first prospective, randomized, controlled, blinded trial in the U.S. of a cerebral protection device for transcatheter aortic valve replacement.

In Brief: India Animal Test Ban; Lauder Acquires Le Labo; More

India bans imported cosmetics tested on animals, firms continue to settle in a Prop 65 suit concerning respirable TiO2 use; Lauder acquires fragrance and sensory lifestyle brand Le Labo. News in brief.

ECHA Launches REACH 2018 Web Portal For Low-Tonnage Registrants

New pages on the European Chemicals Agency’s website are targeted to firms facing registration and reporting requirements under the REACH program’s May 31, 2018 deadline. Addressing seven “phases” of registration, the REACH 2018 portal provid...

Weekly Trademark Review Oct 14, 2014

Class 3 (Cosmetics and Cleaning Preps) compiled by “The Rose Sheet” from Official Gazette of the U.S. Patent and Trademark Office Product Name Trademark No./ Serial N...

Group B streptococcus incidence rises significantly among newborns

The findings suggest that this disturbing trend could be due the emergence of more virulent group B streptococcal strains and call for a renewed evaluation of preventive strategies to reduce neonatal more

In Ebola's presence, leave no skin uncovered

Improve protective gear for health care workers, says NIH's Dr. Anthony Fauci.

Throwing the EHR Under the Bus …

By JOHN IRVINE Given what is now known about how the case of Thomas Eric Duncan at Texas Health was handled, the attempt to blame the hospital’s electronic health record for the missed diagnosis sounds pretty lame. But people are still doing it...

Ebola Travel Ban May Bring Other Troubles

The U.S. government has options for restricting travel from the West African nations suffering most from Ebola, but none would fully prevent the virus from entering the country and all would bring complications.

China Biosimilar Discount Expectations May Deter MNCs

Payers and physicians in China are eager to embrace biosimilars despite a lack of regulatory and reimbursement avenues, notes a recent study by global contact research organization ICON PLC.

Why Novo May Need To Watch Sanofi’s Indian Sugar Clinics Play

On Sept. 30 Sanofi India made a seemingly plain announcement: a tie up with the Apollo Hospitals group to collaborate on the expansion of Apollo Sugar Clinics that provide integrated diabetes care programs in India.

Diabetic men with low testosterone at higher risk of atherosclerosis

Men who have low testosterone and Type 2 diabetes face a greater risk of developing atherosclerosis – a condition where plaque builds up in the arteries – than men who have diabetes and normal testosterone levels, according to a new study...

The pain scale: Rating your pain needs context

Pain is one of the few things in life universally common to all races, all ages, virtually all people for the history of time.   Though it is always with us, it is also the most difficult of human feelings to describe or even talk about. Doctors in an attempt to understand the degree to which […]

Why Americans Still Shouldn’t Be Scared Of Catching Ebola

The utter failure of state and federal authorities to protect two nurses who treated a Liberian Ebola patient in Texas make it seem that America’s defenses against this deadly virus have crumbled. That the Centers for Disease Control & Preventi...

​Immersed in Violence: How 3-D Gaming Affects Video Game Players

Playing violent video games in 3-D makes everything seem more […]

Search BioPortfolio: